Activist 13D/13G Filings - Aevi Genomic Medicine Inc. (GNMX)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2020-02-14
4:14 pm
Sale
13GAevi Genomic Medicine Inc.
GNMX
BAKER BROS. ADVISORS LP564,844
0.700%
-3,385,575decrease
(-85.70%)
View
2020-02-12
4:28 pm
Sale
13GAevi Genomic Medicine Inc.
GNMX
ADAGE CAPITAL PARTNERS GP L.L.C.423,633
0.540%
-5,076,367decrease
(-92.30%)
View
2020-02-07
12:56 pm
Purchase
13DAevi Genomic Medicine Inc.
GNMX
ASTRAZENECA PLC
AZN
12,946,900
16.700%
12,946,900increase
(New Position)
View
2020-01-06
4:06 pm
Purchase
13DAevi Genomic Medicine Inc.
GNMX
Children's Hospital of Philadelphia Foundation57,280,927
49.100%
6,473,450increase
(+12.74%)
View